213 related articles for article (PubMed ID: 28754655)
21. A Study of Gene Expression, Structure, and Contractility of iPSC-Derived Cardiac Myocytes from a Family with Heart Disease due to LMNA Mutation.
Mehrabi M; Morris TA; Cang Z; Nguyen CHH; Sha Y; Asad MN; Khachikyan N; Greene TL; Becker DM; Nie Q; Zaragoza MV; Grosberg A
Ann Biomed Eng; 2021 Dec; 49(12):3524-3539. PubMed ID: 34585335
[TBL] [Abstract][Full Text] [Related]
22. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
[TBL] [Abstract][Full Text] [Related]
23. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
[TBL] [Abstract][Full Text] [Related]
24.
Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
[TBL] [Abstract][Full Text] [Related]
26. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
27. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His.
Oh J; Lee SH; Choi J; Choi JR; Kim S; Cha YJ; Choi HK; Won D; Yoon HG; Park SW; Kang SM; Lee ST; Lee SH
Stem Cell Res; 2021 Oct; 56():102508. PubMed ID: 34438160
[TBL] [Abstract][Full Text] [Related]
29. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
30. Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.
Cattelan G; Sophie Frommelt L; Volani C; Colliva A; Ciucci G; Paldino A; Dal Ferro M; Di Segni M; Silipigni R; Pramstaller PP; De Bortoli M; Zacchigna S; Rossini A
Stem Cell Res; 2023 Sep; 71():103172. PubMed ID: 37535990
[TBL] [Abstract][Full Text] [Related]
31. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
[TBL] [Abstract][Full Text] [Related]
33. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
Sayed N; Liu C; Ameen M; Himmati F; Zhang JZ; Khanamiri S; Moonen JR; Wnorowski A; Cheng L; Rhee JW; Gaddam S; Wang KC; Sallam K; Boyd JH; Woo YJ; Rabinovitch M; Wu JC
Sci Transl Med; 2020 Jul; 12(554):. PubMed ID: 32727917
[TBL] [Abstract][Full Text] [Related]
35. Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations.
Le Dour C; Chatzifrangkeskou M; Macquart C; Magiera MM; Peccate C; Jouve C; Virtanen L; Heliö T; Aalto-Setälä K; Crasto S; Cadot B; Cardoso D; Mougenot N; Adesse D; Di Pasquale E; Hulot JS; Taimen P; Janke C; Muchir A
Nat Commun; 2022 Dec; 13(1):7886. PubMed ID: 36550158
[TBL] [Abstract][Full Text] [Related]
36. Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.
Geiger SK; Bär H; Ehlermann P; Wälde S; Rutschow D; Zeller R; Ivandic BT; Zentgraf H; Katus HA; Herrmann H; Weichenhan D
J Mol Med (Berl); 2008 Mar; 86(3):281-9. PubMed ID: 17987279
[TBL] [Abstract][Full Text] [Related]
37. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
Parks SB; Kushner JD; Nauman D; Burgess D; Ludwigsen S; Peterson A; Li D; Jakobs P; Litt M; Porter CB; Rahko PS; Hershberger RE
Am Heart J; 2008 Jul; 156(1):161-9. PubMed ID: 18585512
[TBL] [Abstract][Full Text] [Related]
38. Generation of an iPSC cell line (USFi003-A) from a patient with dilated cardiomyopathy carrying a heterozygous mutation in LMNA (p.R541C).
Yang J; Burgos Angulo M; Argenziano MA; Bertalovitz A; Najari Beidokhti M; McDonald TV
Stem Cell Res; 2021 Jul; 54():102396. PubMed ID: 34029931
[TBL] [Abstract][Full Text] [Related]
39. Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients.
Sarkar C; Zhang Z; Mukherjee AB
Mol Genet Metab; 2011 Nov; 104(3):338-45. PubMed ID: 21704547
[TBL] [Abstract][Full Text] [Related]
40. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
Yamada S; Ko T; Ito M; Sassa T; Nomura S; Okuma H; Sato M; Imasaki T; Kikkawa S; Zhang B; Yamada T; Seki Y; Fujita K; Katoh M; Kubota M; Hatsuse S; Katagiri M; Hayashi H; Hamano M; Takeda N; Morita H; Takada S; Toyoda M; Uchiyama M; Ikeuchi M; Toyooka K; Umezawa A; Yamanishi Y; Nitta R; Aburatani H; Komuro I
Sci Adv; 2023 Apr; 9(15):eade7047. PubMed ID: 37058558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
